Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ASTH · against 588 other Healthcare companies listed in US-listed
Ranked #144 of 589 · scores higher than 75% of peers
Bars: peers in each 10-point band of the valuation score57 peers with a valuation score of 50–59, including ASTH · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | ASTH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 2.3% | -4.3% | 74% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 7.9% | -0.8% | 82% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 5.2% | -2.3% | 84% | 20% | |
| Book yieldHigher is better · 587 reported | 45.9% | 25.9% | 71% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 139 | 12.6B USD | 58 | 55 | |
| 139 | 2.2B USD | 58 | 61 | |
| 144 | 189.3B USD | 57 | 45 | |
| 144 | 2.8B USD | 57 | 33 | |
| 144 | 1.8B USD | 57 | 52 | |
| 144 | 2.9B USD | 57 | 50 | |
| 144 | 54.0B USD | 57 | 47 | |
| 144 | 31.3B USD | 57 | 63 | |
| 144 | 8.4B USD | 57 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score